Pharmaids Pharmaceuticals has informed that the Meeting of Board of Directors of the Company is scheduled to be held on Thursday, October 13, 2022, at 2.30 pm at the Registered Office of the Company, to consider and allot 54,00,000 Equity Share Warrants of Face Value of Rs 10 each at a Price of Rs 15 Per Share (Inclusive of Share Premium of Rs 5 Per Share) on Preferential Basis, in accordance with the provisions of Chapter V of the SEBI (Issue of Capital and Disclosure Requirements) Regulations, 2018, in terms of approval accorded by the Shareholders at the 33rd Annual General Meeting of the Company for the purpose and in terms of the In-principle approval dated September 29, 2022 received from BSE.
The above information is a part of company’s filings submitted to BSE.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1668.00 |
| Dr. Reddys Lab | 1232.25 |
| Cipla | 1228.90 |
| Zydus Lifesciences | 936.35 |
| Lupin | 2328.60 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: